IV Fentanyl
Phase 3Small molecule
IV Fentanyl is one of 34 small molecule programs targeting Abortion. It is currently in Phase 3.
1
Indications
5
Total Trials
1
Active Trials
33
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
97 competitors in Abortion
#DrugCompanyPhaseTrials
1Mifeprex
DDanco
Approved
Prometrium
FerringApproved
Versed
CConrado Roberto Hoffmann Filho
Approved
Advil
KKenvue Brands
Phase 3
Oxycontin
PProtega
Phase 3
Dostinex
PfizerPhase 2
Enoxaparine
SanofiPhase 3
Dextromethorphan Hydrobromide
Boehringer IngelheimPhase 3
Anerem
AAcacia Pharma Ltd
Phase 2
Spravato
WWim Janssens
Phase 2
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Fentanyl1 trial
Abortion1 trial
Intravenous Ketamine for Pain Control During First Trimester Surgical Abortion
Suspended·—·Phase 3·NCT03751423·123 enrolled
Ambulatory Surgery1 trial
Extracorporeal Shockwave Lithotripsy1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for IV Fentanyl. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Phase 3[1]
- Company
- YYM BioSciences